TABLE 1.
Clinical characteristics of 9 enrolled CCA patients.
| Clinicopathological variables | Patient number (n = 9) | Percentage (100%) |
| Sex | ||
| Male | 5 | 55.6 |
| Female | 4 | 44.4 |
| Age at first enrolled year, Mean ± SD | 62.44 ± 11.78 | |
| HBV infection | ||
| Negative | 6 | 66.7 |
| Positive | 3 | 33.3 |
| HBV DNA | ||
| ≤103 | 7 | 77.8 |
| 103–104 | 1 | 11.1 |
| 104–105 | 1 | 11.1 |
| Maximal tumor size, cm | ||
| 0–2.5 | 2 | 22.2 |
| 2.5–5.0 | 2 | 22.2 |
| 5.0–10 | 5 | 55.6 |
| Tumor number | ||
| Single | 8 | 88.9 |
| Multiple | 1 | 11.1 |
| Liver cirrhosis | ||
| Absent | 5 | 55.6 |
| Present | 4 | 44.4 |
| Microvascular invasion | ||
| Yes | 3 | 33.3 |
| No | 6 | 66.7 |
| PVTT | ||
| Yes | 1 | 11.1 |
| No | 8 | 88.9 |
| Microsatellite lesion | ||
| Absent | 8 | 88.9 |
| Present | 1 | 11.1 |
| TNM | ||
| I | 5 | 55.6 |
| II | 1 | 11.1 |
| IV | 3 | 33.3 |
| BCLC | ||
| 0 | 1 | 11.1 |
| A | 4 | 44.5 |
| B | 1 | 11.1 |
| C | 3 | 33.3 |
PVTT, Portal vein tumor thrombosis; TNM, The TNM Classification of Malignant Tumors; BCLC, the Barcelona Clinic Liver Cancer staging system.